Cosmos Health (COSM) Assets Average (2012 - 2026)
Cosmos Health's (COSM) quarterly Assets Average came in at $61.9 million in Q2 2026, up 4.04% on a YoY basis from $59.5 million in Q2 2025, and down 3.14% quarter-over-quarter from $63.9 million in Q1 2026.
Analysis
Cosmos Health (COSM) Assets Average (2012 - 2026) Analysis & Trends
Cosmos Health (COSM) has reported Assets Average for 15 consecutive years, with $61.9 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Assets Average rose 4.04% year-over-year to $61.9 million; the trailing twelve-month figure through Jun 2026 stood at $61.9 million (up 4.04% YoY), and the FY2025 full-year result was $59.9 million, changed 0.45% from the prior year.
- Assets Average retreated to $61.9 million in Q2 2026 per COSM's latest filing, from $63.9 million in the prior quarter.
- Across five years, Assets Average topped out at $70.1 million in Q3 2023 and bottomed at $46.7 million in Q3 2022.
- Historically, Assets Average has averaged $61.1 million across 5 years, with a median of $62.3 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Assets Average soared 49.92% in 2023, then fell 13.6% in 2024.
- Over 5 years, Assets Average stood at $56.8 million in 2022, then increased by 21.01% to $68.8 million in 2023, then retreated by 13.6% to $59.4 million in 2024, then grew by 13.58% to $67.5 million in 2025, then declined by 8.25% to $61.9 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $61.9 million, $63.9 million, and $67.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | 39.95 Bn |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | 35.94 Bn |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | 6.21 Bn |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | 3.66 Bn |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | 24.65 Bn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | 1.50 Bn |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | 1.46 Bn |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 1.70 Bn |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | 73.15 Mn |
| 10 | Cosmos Health | 15.08 Mn | 12.63 Mn | 1.51 Mn | 61.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 61.92 Mn |
| Mar 31, 2026 | 63.92 Mn |
| Dec 31, 2025 | 67.49 Mn |
| Sep 30, 2025 | 65.66 Mn |
| Jun 30, 2025 | 59.51 Mn |
| Mar 31, 2025 | 55.75 Mn |
| Dec 31, 2024 | 59.42 Mn |
| Sep 30, 2024 | 62.67 Mn |
| Jun 30, 2024 | 61.59 Mn |
| Mar 31, 2024 | 64.18 Mn |
| Dec 31, 2023 | 68.77 Mn |
| Sep 30, 2023 | 70.06 Mn |
| Jun 30, 2023 | 68.30 Mn |
| Mar 31, 2023 | 68.03 Mn |
| Dec 31, 2022 | 56.83 Mn |
| Sep 30, 2022 | 46.73 Mn |
| Jun 30, 2022 | 48.81 Mn |
| Mar 31, 2022 | 49.60 Mn |
| Dec 31, 2021 | 48.55 Mn |
| Sep 30, 2021 | 46.42 Mn |